NBIX vs REGCP
Neurocrine Biosciences Inc (NBIX) versus Regency Centers Corporation 6.25% Series A Cumulative Redeemable Preferred Stock (REGCP) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Regency Centers Corporation 6.25% Series A Cumulative Redeemable Preferred Stock (REGCP) is a reit - retail company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
REGCP does not have a complete income-statement cache yet.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. REGCP currently screens at market cap $0.
Not investment advice. Open the NBIX and REGCP stock pages for the full models.
Not investment advice.